Home | Welcome to Contract Pharma   
Last Updated Saturday, July 26 2014
Print

Breaking News

Related Searches:
June 14, 2010
Movement atop Softgels, other Catalent units  Read More »
June 14, 2010
Bayer, Onyx drug shows no survival improvement in study  Read More »
June 14, 2010
BMS to improve efficiencies with growing pipeline  Read More »
June 11, 2010
Commercial manufacturing revenues were up 5% in the quarter to $142.2 million.  Read More »
June 11, 2010
Patheon has signed an expanded contract manufacturing agreement with Merck.   Read More »
June 11, 2010
Hani S. Zaki has been appointed senior vice president of PRA International’s Late Phase Services (LPS).   Read More »
June 10, 2010
Xcellerex, Inc. began construction of a cGMP FlexFactory biomanufacturing facility at its headquarters in Marlborough, MA, with completion scheduled for September 2010.  Read More »
June 10, 2010
Human Genome Sciences, Inc. (HGS) has submitted a BLA to the FDA for approval to market Benlysta (belimumab) for the treatment of systemic lupus erythematosus (SLE).  Read More »
June 10, 2010
Nextrials, Inc. has integrated its EDC and clinical trial data management platform Prism with the study design tools offered by Formedix, which includes database design tools based on CDISC data standards.  Read More »
June 9, 2010
DSM BioSolutions has entered into an agreement with Novacta Biosystems Ltd. for the process development and cGMP production of its C. difficile molecule, a new class of lantibiotic compounds.  Read More »
June 9, 2010
Enavail, LLC, a particle engineering company has plans to build a new cGMP facility in the Abilene Life Sciences Accelerator (ALSA).   Read More »
June 9, 2010
Covance, Inc. has opened a new 20,000-sq.-ft. biorepository facility at its Greenfield, IN location, dedicated to long-term storage of clinical trial specimens.  Read More »
June 8, 2010
Hospira and Durect Corp. have entered into a licensing agreement to develop and market Durect’s Posidur (SABER-bupivacaine), a long-acting version of the anesthetic bupivacaine, currently in Phase III trials.  Read More »
June 8, 2010
QPharma, Inc. has launched its Engineering Services group, which will provide the resources necessary to manage, design, construct, commission, and validate the execution of projects for the life sciences and related industries.  Read More »
June 8, 2010
TransTech Pharma and Forest Laboratories have entered into a license agreement for the development and commercialization of small molecule compounds discovered by TransTech.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On